Who
Kerry Wentworth
Chief Regulatory Officer
Company insider
Files Form 4 as: Chief Regulatory Officer, Nuvation Bio; Chief Regulatory Officer, Flexion Therapeutics; VP, Clinical, Reg & Qual, Agenus.
In numbers
- Trades disclosed
- 143
- Buys
- 1
- Sells
- 24
- Bought
- $90K
- Sold
- $3.4M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 15 Sep 2006
- Last trade
- 23 Jun 2026
- Last filed
- 24 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $185K63,000 at $2.93 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $379K63,000 at $6.02 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —63,000 at $0.00 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —63,000 at $0.00 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $185K63,000 at $2.93 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $379K63,000 at $6.02 | filing |
| 17 Apr 2026filed 21 Apr 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $108K36,750 at $2.93 | filing |
| 17 Apr 2026filed 21 Apr 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $184K36,750 at $5.01 | filing |
| 17 Apr 2026filed 21 Apr 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —36,750 at $0.00 | filing |
| 17 Apr 2026filed 21 Apr 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —36,750 at $0.00 | filing |
| 17 Apr 2026filed 21 Apr 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $108K36,750 at $2.93 | filing |
| 17 Apr 2026filed 21 Apr 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $184K36,750 at $5.01 | filing |
| 6 Apr 2026filed 8 Apr 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $187K100,000 at $1.87 | filing |
| 6 Apr 2026filed 8 Apr 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $194K100,000 at $1.94 | filing |
| 6 Apr 2026filed 8 Apr 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $904K200,000 at $4.52 | filing |
| 6 Apr 2026filed 8 Apr 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 6 Apr 2026filed 8 Apr 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 6 Apr 2026filed 8 Apr 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 6 Apr 2026filed 8 Apr 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 6 Apr 2026filed 8 Apr 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $187K100,000 at $1.87 | filing |
News
Critical Review: Nuvation Bio (NYSE:NUVB) vs. OSR (NASDAQ:OSRH)NUVB · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Kerry Wentworth; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.